Edward Grimley Selected Research

1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)

1/2021

Aldehyde dehydrogenase inhibitors promote DNA damage in ovarian cancer and synergize with ATM/ATR inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward Grimley Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 01/2017
4	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2018
1	Polyploidy 01/2022
1	Fibrosis (Cirrhosis) 01/2019
1	Kidney Neoplasms (Kidney Cancer) 01/2018
1	Kidney Diseases (Kidney Disease) 01/2018
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2018
1	Obesity 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
4	Aldehyde DehydrogenaseIBA 02/2021 - 10/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Protein Isoforms (Isoforms)IBA 02/2021 - 10/2018
2	chordinIBA 01/2019 - 01/2017
1	MTOR InhibitorsIBA 01/2022
1	EnzymesIBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 10/2018

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 02/2021 - 10/2018
1	Therapeutics 01/2022